Toxicologists are scientific experts who study the harmful effects of chemicals, substances, and environmental agents on living organisms. Their work is essential in assessing the safety of pharmaceuticals, food additives, industrial chemicals, and cosmetics before these products reach the public. By conducting laboratory experiments, animal studies, and cellular assays, toxicologists determine safe exposure levels and identify potential health risks. They play a critical role in drug development by helping to evaluate toxicity profiles and ensure that new treatments meet safety regulations. Their insights also inform regulatory guidelines and public health policies that protect people from environmental hazards.
Toxicologists are often involved in forensic investigations, environmental assessments, and risk analysis. They collaborate with healthcare professionals, regulatory agencies, and environmental scientists to interpret data and recommend actions in cases of contamination, poisoning, or chemical exposure. Their expertise is particularly valuable in addressing concerns related to pollution, occupational safety, and the long-term health effects of chronic exposure to various substances. With advancements in analytical technology and molecular toxicology, toxicologists can now better understand how toxins interact with genes and cellular processes. Their work forms the foundation for ensuring public safety in an increasingly chemical-dependent world. As new chemicals are introduced into our environment, toxicologists remain essential in safeguarding health and maintaining ecological balance.
Title : A promising novel approach to DNA vaccines
Khursheed Anwer, IMUNON, United States
Title : Nanoscopic SubATVax™ adjuvanted vaccines against influenza A types H3N2, H1N1 and influenza type B for subcutaneous administration
David Craig Wright, D4 Labs, LLC, United States
Title : The importance of post-marketing surveillance and real-world data: For a product to be successful
Regina Au, BioMarketing Insight, United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Homology analysis of MPXV and VACV peptides underscores the need to consider both MPXV clades for vaccine development
Lara Isis Teodoro, Mayo Clinic, United States
Title : High seroprevalence of RSV antibodies in adults indicates potential undetected transmission and requires further public health assessment
Lara Isis Teodoro, Mayo Clinic, United States
Title : Commensal bacteria drive B-cell lymphomagenesis in the setting of innate immunodeficiency
Ping Xie, Rutgers University, United States
Title : The role of immunity in the pathogenesis of SARS-COV-2 and in the protection generated by COVID-19 in different age groups
Ahmed Abdulazeez, BHRUT Trust, United Kingdom
Title : Establishing a platform method for physical appearance assessment of new parenteral pharmaceuticals
Ying Wan, Merck & Co., United States
Title : Tubercular disease in children: Optimizing treatment strategies through disease insights
Elena Chiappini, University of Florence, Italy